A service of StreetInsider.com

Most Popular

AAPL 196.19
C 3.18
GOOG 536.44
BAC 14.47
RIMM 66.15

Recently Added

TNGN 0.00
SWS 12.17
ATHX 2.88
MED 17.54
DANA 0.20

Gaining Speed

CTGI 0.14
MKSI 18.55
SWS 12.17
WHX 17.61
SEWE 0.95
53.58 +0.00 (0.00%) NVS

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:53.58 Change:+0.00 (0.00%) Prev Close:53.58 Open: 53.23 Days Range:53.06 – 53.79 52 Week Range: 33.34 - 56.42 Volume:2507700 P/E: N/A
EPS:0.00

Member Comments

No member comments available for NVS


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 02/10/10

Recent Alert on 02/09/10 at 9:11am
Novartis (NVS) Gains Rights to Develop and Distribute Debio 025; Currently in Phase IIb

Novartis (NYSE: NVS) has gained exclusive rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent currently in Phase IIb development for the treatment of hepatitis C. Debio 025 is the first in a new class of... Read More

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 02/09/10 at 12:02pm
Form 6-K NOVARTIS AG For: Feb 09
SEC Filing on 02/09/10 at 6:16am
Form 6-K NOVARTIS AG For: Feb 09

View AllRecent Blog Posts

Blog Posts on 02/09/10 at 1:25pm
Amgen Sees Positive Results from Osteoporosis Drug
Blog Posts on 02/01/10 at 6:55am
Novartis Makes Notable CEO Pick
Blog Posts on 01/26/10 at 3:50pm
Novartis 2009 Annual Conference Call Transcript
Blog Posts on 01/25/10 at 11:27am
Report from Europe: Bears Come Out of Hibernation